nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—BCL2—Docetaxel—stomach cancer	0.58	0.951	CbGbCtD
Rasagiline—CYP1A2—Fluorouracil—stomach cancer	0.0297	0.0487	CbGbCtD
Rasagiline—BCL2—hematopoietic system—stomach cancer	0.00378	0.126	CbGeAlD
Rasagiline—BCL2—epithelium—stomach cancer	0.00346	0.115	CbGeAlD
Rasagiline—BCL2—smooth muscle tissue—stomach cancer	0.00333	0.111	CbGeAlD
Rasagiline—BCL2—lymphoid tissue—stomach cancer	0.00266	0.0884	CbGeAlD
Rasagiline—BCL2—digestive system—stomach cancer	0.00263	0.0874	CbGeAlD
Rasagiline—BCL2—bone marrow—stomach cancer	0.00242	0.0805	CbGeAlD
Rasagiline—BCL2—endocrine gland—stomach cancer	0.00217	0.0722	CbGeAlD
Rasagiline—MAOB—hematopoietic system—stomach cancer	0.00157	0.0523	CbGeAlD
Rasagiline—BCL2—lymph node—stomach cancer	0.0015	0.0499	CbGeAlD
Rasagiline—CYP1A2—hematopoietic system—stomach cancer	0.00112	0.0372	CbGeAlD
Rasagiline—MAOB—digestive system—stomach cancer	0.00109	0.0364	CbGeAlD
Rasagiline—MAOB—endocrine gland—stomach cancer	0.000904	0.0301	CbGeAlD
Rasagiline—MAOB—liver—stomach cancer	0.000815	0.0271	CbGeAlD
Rasagiline—CYP1A2—digestive system—stomach cancer	0.000779	0.0259	CbGeAlD
Rasagiline—CYP1A2—endocrine gland—stomach cancer	0.000644	0.0214	CbGeAlD
Rasagiline—MAOB—lymph node—stomach cancer	0.000625	0.0208	CbGeAlD
Rasagiline—CYP1A2—liver—stomach cancer	0.00058	0.0193	CbGeAlD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	0.000126	0.00084	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—LGALS3—stomach cancer	0.000125	0.000836	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—stomach cancer	0.000124	0.000831	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—KRAS—stomach cancer	0.000123	0.000824	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—MAPK1—stomach cancer	0.000121	0.000811	CbGpPWpGaD
Rasagiline—BCL2—Immune System—POLR3K—stomach cancer	0.00012	0.000804	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PGLS—stomach cancer	0.00012	0.0008	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—BLVRB—stomach cancer	0.00012	0.0008	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—GSTT1—stomach cancer	0.000118	0.000787	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	0.000117	0.000782	CbGpPWpGaD
Rasagiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000115	0.000768	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPAP2A—stomach cancer	0.000114	0.000763	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PYCARD—stomach cancer	0.000114	0.000762	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—JUN—stomach cancer	0.00011	0.000737	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—stomach cancer	0.00011	0.000732	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—MAPK1—stomach cancer	0.000109	0.00073	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—MYC—stomach cancer	0.000108	0.000724	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—CDKN1A—stomach cancer	0.000107	0.000715	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—MAPK1—stomach cancer	0.000106	0.000708	CbGpPWpGaD
Rasagiline—Sweating—Doxorubicin—stomach cancer	0.000106	0.000503	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—RHOA—stomach cancer	0.000106	0.000708	CbGpPWpGaD
Rasagiline—Urinary tract disorder—Epirubicin—stomach cancer	0.000106	0.000503	CcSEcCtD
Rasagiline—Hyperhidrosis—Capecitabine—stomach cancer	0.000106	0.000502	CcSEcCtD
Rasagiline—Oedema peripheral—Epirubicin—stomach cancer	0.000106	0.000501	CcSEcCtD
Rasagiline—Hypotension—Docetaxel—stomach cancer	0.000106	0.000501	CcSEcCtD
Rasagiline—Haematuria—Doxorubicin—stomach cancer	0.000105	0.0005	CcSEcCtD
Rasagiline—Connective tissue disorder—Epirubicin—stomach cancer	0.000105	0.0005	CcSEcCtD
Rasagiline—Urethral disorder—Epirubicin—stomach cancer	0.000105	0.000499	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—IRF1—stomach cancer	0.000105	0.000702	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—HRAS—stomach cancer	0.000105	0.0007	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TXNIP—stomach cancer	0.000104	0.000697	CbGpPWpGaD
Rasagiline—Epistaxis—Doxorubicin—stomach cancer	0.000104	0.000495	CcSEcCtD
Rasagiline—Anorexia—Capecitabine—stomach cancer	0.000104	0.000495	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CCND1—stomach cancer	0.000104	0.000695	CbGpPWpGaD
Rasagiline—Angiopathy—Methotrexate—stomach cancer	0.000104	0.000494	CcSEcCtD
Rasagiline—Vomiting—Irinotecan—stomach cancer	0.000104	0.000493	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—JUN—stomach cancer	0.000104	0.000694	CbGpPWpGaD
Rasagiline—Immune system disorder—Methotrexate—stomach cancer	0.000103	0.000491	CcSEcCtD
Rasagiline—Dizziness—Fluorouracil—stomach cancer	0.000103	0.000491	CcSEcCtD
Rasagiline—Mediastinal disorder—Methotrexate—stomach cancer	0.000103	0.00049	CcSEcCtD
Rasagiline—Rash—Irinotecan—stomach cancer	0.000103	0.000489	CcSEcCtD
Rasagiline—Dermatitis—Irinotecan—stomach cancer	0.000103	0.000489	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000103	0.000488	CcSEcCtD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—TP53—stomach cancer	0.000103	0.000687	CbGpPWpGaD
Rasagiline—Chills—Methotrexate—stomach cancer	0.000103	0.000488	CcSEcCtD
Rasagiline—Headache—Irinotecan—stomach cancer	0.000102	0.000486	CcSEcCtD
Rasagiline—BCL2—Immune System—MT2A—stomach cancer	0.000102	0.000684	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CTSC—stomach cancer	0.000102	0.000684	CbGpPWpGaD
Rasagiline—Hypotension—Capecitabine—stomach cancer	0.000102	0.000485	CcSEcCtD
Rasagiline—Insomnia—Docetaxel—stomach cancer	0.000102	0.000485	CcSEcCtD
Rasagiline—MAOB—Metabolism—CA1—stomach cancer	0.000102	0.00068	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—FBP1—stomach cancer	0.000102	0.00068	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NDUFA2—stomach cancer	0.000102	0.00068	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CKB—stomach cancer	0.000102	0.00068	CbGpPWpGaD
Rasagiline—Paraesthesia—Docetaxel—stomach cancer	0.000101	0.000481	CcSEcCtD
Rasagiline—Alopecia—Methotrexate—stomach cancer	0.000101	0.000481	CcSEcCtD
Rasagiline—Dyspnoea—Docetaxel—stomach cancer	0.000101	0.000478	CcSEcCtD
Rasagiline—Somnolence—Docetaxel—stomach cancer	0.0001	0.000477	CcSEcCtD
Rasagiline—Mental disorder—Methotrexate—stomach cancer	0.0001	0.000477	CcSEcCtD
Rasagiline—Eye disorder—Epirubicin—stomach cancer	0.0001	0.000476	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—KRAS—stomach cancer	0.0001	0.000669	CbGpPWpGaD
Rasagiline—Malnutrition—Methotrexate—stomach cancer	9.97e-05	0.000474	CcSEcCtD
Rasagiline—Haemoglobin—Doxorubicin—stomach cancer	9.97e-05	0.000473	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Capecitabine—stomach cancer	9.96e-05	0.000473	CcSEcCtD
Rasagiline—Cardiac disorder—Epirubicin—stomach cancer	9.95e-05	0.000472	CcSEcCtD
Rasagiline—Vomiting—Fluorouracil—stomach cancer	9.95e-05	0.000472	CcSEcCtD
Rasagiline—Rhinitis—Doxorubicin—stomach cancer	9.94e-05	0.000472	CcSEcCtD
Rasagiline—Dyspepsia—Docetaxel—stomach cancer	9.94e-05	0.000472	CcSEcCtD
Rasagiline—Haemorrhage—Doxorubicin—stomach cancer	9.92e-05	0.000471	CcSEcCtD
Rasagiline—Insomnia—Capecitabine—stomach cancer	9.89e-05	0.00047	CcSEcCtD
Rasagiline—Hypoaesthesia—Doxorubicin—stomach cancer	9.87e-05	0.000469	CcSEcCtD
Rasagiline—Rash—Fluorouracil—stomach cancer	9.86e-05	0.000468	CcSEcCtD
Rasagiline—Dermatitis—Fluorouracil—stomach cancer	9.86e-05	0.000468	CcSEcCtD
Rasagiline—Paraesthesia—Capecitabine—stomach cancer	9.82e-05	0.000466	CcSEcCtD
Rasagiline—Decreased appetite—Docetaxel—stomach cancer	9.82e-05	0.000466	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—ERBB2—stomach cancer	9.8e-05	0.000655	CbGpPWpGaD
Rasagiline—Headache—Fluorouracil—stomach cancer	9.8e-05	0.000465	CcSEcCtD
Rasagiline—Urinary tract disorder—Doxorubicin—stomach cancer	9.8e-05	0.000465	CcSEcCtD
Rasagiline—Oedema peripheral—Doxorubicin—stomach cancer	9.77e-05	0.000464	CcSEcCtD
Rasagiline—Dysgeusia—Methotrexate—stomach cancer	9.77e-05	0.000464	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	9.76e-05	0.000652	CbGpPWpGaD
Rasagiline—Gastrointestinal disorder—Docetaxel—stomach cancer	9.75e-05	0.000463	CcSEcCtD
Rasagiline—Connective tissue disorder—Doxorubicin—stomach cancer	9.75e-05	0.000463	CcSEcCtD
Rasagiline—Dyspnoea—Capecitabine—stomach cancer	9.75e-05	0.000463	CcSEcCtD
Rasagiline—Angiopathy—Epirubicin—stomach cancer	9.73e-05	0.000462	CcSEcCtD
Rasagiline—Urethral disorder—Doxorubicin—stomach cancer	9.72e-05	0.000462	CcSEcCtD
Rasagiline—Nausea—Irinotecan—stomach cancer	9.7e-05	0.000461	CcSEcCtD
Rasagiline—Immune system disorder—Epirubicin—stomach cancer	9.68e-05	0.00046	CcSEcCtD
Rasagiline—Mediastinal disorder—Epirubicin—stomach cancer	9.66e-05	0.000459	CcSEcCtD
Rasagiline—Constipation—Docetaxel—stomach cancer	9.66e-05	0.000459	CcSEcCtD
Rasagiline—Back pain—Methotrexate—stomach cancer	9.65e-05	0.000458	CcSEcCtD
Rasagiline—Dyspepsia—Capecitabine—stomach cancer	9.62e-05	0.000457	CcSEcCtD
Rasagiline—BCL2—Apoptosis—MAPK8—stomach cancer	9.62e-05	0.000643	CbGpPWpGaD
Rasagiline—Chills—Epirubicin—stomach cancer	9.62e-05	0.000457	CcSEcCtD
Rasagiline—MAOB—Metabolism—PLIN2—stomach cancer	9.57e-05	0.00064	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	9.54e-05	0.000638	CbGpPWpGaD
Rasagiline—Decreased appetite—Capecitabine—stomach cancer	9.5e-05	0.000451	CcSEcCtD
Rasagiline—Alopecia—Epirubicin—stomach cancer	9.47e-05	0.00045	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Capecitabine—stomach cancer	9.44e-05	0.000448	CcSEcCtD
Rasagiline—Mental disorder—Epirubicin—stomach cancer	9.39e-05	0.000446	CcSEcCtD
Rasagiline—Constipation—Capecitabine—stomach cancer	9.35e-05	0.000444	CcSEcCtD
Rasagiline—Malnutrition—Epirubicin—stomach cancer	9.33e-05	0.000443	CcSEcCtD
Rasagiline—MAOB—Metabolism—CA2—stomach cancer	9.31e-05	0.000622	CbGpPWpGaD
Rasagiline—Feeling abnormal—Docetaxel—stomach cancer	9.31e-05	0.000442	CcSEcCtD
Rasagiline—Nausea—Fluorouracil—stomach cancer	9.29e-05	0.000441	CcSEcCtD
Rasagiline—Eye disorder—Doxorubicin—stomach cancer	9.27e-05	0.00044	CcSEcCtD
Rasagiline—Ill-defined disorder—Methotrexate—stomach cancer	9.25e-05	0.000439	CcSEcCtD
Rasagiline—Gastrointestinal pain—Docetaxel—stomach cancer	9.23e-05	0.000438	CcSEcCtD
Rasagiline—Anaemia—Methotrexate—stomach cancer	9.22e-05	0.000438	CcSEcCtD
Rasagiline—Cardiac disorder—Doxorubicin—stomach cancer	9.21e-05	0.000437	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—PIK3CA—stomach cancer	9.2e-05	0.000615	CbGpPWpGaD
Rasagiline—Flatulence—Epirubicin—stomach cancer	9.2e-05	0.000437	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TP53—stomach cancer	9.17e-05	0.000613	CbGpPWpGaD
Rasagiline—Dysgeusia—Epirubicin—stomach cancer	9.14e-05	0.000434	CcSEcCtD
Rasagiline—MAOB—Metabolism—PGAM1—stomach cancer	9.08e-05	0.000607	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NT5E—stomach cancer	9.08e-05	0.000607	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—VEGFA—stomach cancer	9.07e-05	0.000606	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	9.04e-05	0.000604	CbGpPWpGaD
Rasagiline—Back pain—Epirubicin—stomach cancer	9.03e-05	0.000429	CcSEcCtD
Rasagiline—Feeling abnormal—Capecitabine—stomach cancer	9.01e-05	0.000428	CcSEcCtD
Rasagiline—Angiopathy—Doxorubicin—stomach cancer	9e-05	0.000427	CcSEcCtD
Rasagiline—Malaise—Methotrexate—stomach cancer	8.99e-05	0.000427	CcSEcCtD
Rasagiline—Muscle spasms—Epirubicin—stomach cancer	8.97e-05	0.000426	CcSEcCtD
Rasagiline—Immune system disorder—Doxorubicin—stomach cancer	8.96e-05	0.000425	CcSEcCtD
Rasagiline—Vertigo—Methotrexate—stomach cancer	8.96e-05	0.000425	CcSEcCtD
Rasagiline—Gastrointestinal pain—Capecitabine—stomach cancer	8.94e-05	0.000424	CcSEcCtD
Rasagiline—Mediastinal disorder—Doxorubicin—stomach cancer	8.94e-05	0.000424	CcSEcCtD
Rasagiline—Body temperature increased—Docetaxel—stomach cancer	8.93e-05	0.000424	CcSEcCtD
Rasagiline—Abdominal pain—Docetaxel—stomach cancer	8.93e-05	0.000424	CcSEcCtD
Rasagiline—Leukopenia—Methotrexate—stomach cancer	8.93e-05	0.000424	CcSEcCtD
Rasagiline—Chills—Doxorubicin—stomach cancer	8.9e-05	0.000423	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TP53—stomach cancer	8.9e-05	0.000595	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—HRAS—stomach cancer	8.77e-05	0.000586	CbGpPWpGaD
Rasagiline—Alopecia—Doxorubicin—stomach cancer	8.77e-05	0.000416	CcSEcCtD
Rasagiline—Cough—Methotrexate—stomach cancer	8.7e-05	0.000413	CcSEcCtD
Rasagiline—Mental disorder—Doxorubicin—stomach cancer	8.69e-05	0.000413	CcSEcCtD
Rasagiline—Urticaria—Capecitabine—stomach cancer	8.69e-05	0.000412	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—EGFR—stomach cancer	8.67e-05	0.00058	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—CCND1—stomach cancer	8.66e-05	0.000579	CbGpPWpGaD
Rasagiline—Ill-defined disorder—Epirubicin—stomach cancer	8.66e-05	0.000411	CcSEcCtD
Rasagiline—MAOB—Metabolism—ALDH7A1—stomach cancer	8.66e-05	0.000579	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PLCE1—stomach cancer	8.66e-05	0.000579	CbGpPWpGaD
Rasagiline—Body temperature increased—Capecitabine—stomach cancer	8.64e-05	0.00041	CcSEcCtD
Rasagiline—Abdominal pain—Capecitabine—stomach cancer	8.64e-05	0.00041	CcSEcCtD
Rasagiline—BCL2—Immune System—CASP10—stomach cancer	8.64e-05	0.000578	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—JUN—stomach cancer	8.64e-05	0.000578	CbGpPWpGaD
Rasagiline—Convulsion—Methotrexate—stomach cancer	8.64e-05	0.00041	CcSEcCtD
Rasagiline—Malnutrition—Doxorubicin—stomach cancer	8.63e-05	0.00041	CcSEcCtD
Rasagiline—Anaemia—Epirubicin—stomach cancer	8.63e-05	0.00041	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	8.62e-05	0.000576	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	8.61e-05	0.000575	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—HBEGF—stomach cancer	8.58e-05	0.000573	CbGpPWpGaD
Rasagiline—Agitation—Epirubicin—stomach cancer	8.58e-05	0.000407	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—HRAS—stomach cancer	8.51e-05	0.000569	CbGpPWpGaD
Rasagiline—Flatulence—Doxorubicin—stomach cancer	8.51e-05	0.000404	CcSEcCtD
Rasagiline—Chest pain—Methotrexate—stomach cancer	8.49e-05	0.000403	CcSEcCtD
Rasagiline—Arthralgia—Methotrexate—stomach cancer	8.49e-05	0.000403	CcSEcCtD
Rasagiline—Dysgeusia—Doxorubicin—stomach cancer	8.46e-05	0.000402	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	8.43e-05	0.0004	CcSEcCtD
Rasagiline—Malaise—Epirubicin—stomach cancer	8.42e-05	0.0004	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL6—stomach cancer	8.39e-05	0.000561	CbGpPWpGaD
Rasagiline—Discomfort—Methotrexate—stomach cancer	8.39e-05	0.000398	CcSEcCtD
Rasagiline—Vertigo—Epirubicin—stomach cancer	8.38e-05	0.000398	CcSEcCtD
Rasagiline—Syncope—Epirubicin—stomach cancer	8.37e-05	0.000397	CcSEcCtD
Rasagiline—Leukopenia—Epirubicin—stomach cancer	8.35e-05	0.000397	CcSEcCtD
Rasagiline—Back pain—Doxorubicin—stomach cancer	8.35e-05	0.000397	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—MYC—stomach cancer	8.35e-05	0.000558	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	8.34e-05	0.000558	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MX1—stomach cancer	8.34e-05	0.000557	CbGpPWpGaD
Rasagiline—Hypersensitivity—Docetaxel—stomach cancer	8.32e-05	0.000395	CcSEcCtD
Rasagiline—Muscle spasms—Doxorubicin—stomach cancer	8.3e-05	0.000394	CcSEcCtD
Rasagiline—MAOB—Metabolism—UMPS—stomach cancer	8.3e-05	0.000555	CbGpPWpGaD
Rasagiline—Confusional state—Methotrexate—stomach cancer	8.21e-05	0.00039	CcSEcCtD
Rasagiline—Loss of consciousness—Epirubicin—stomach cancer	8.2e-05	0.000389	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—MAPK8—stomach cancer	8.18e-05	0.000546	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—MAPK1—stomach cancer	8.17e-05	0.000546	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—EGFR—stomach cancer	8.17e-05	0.000546	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—GSTP1—stomach cancer	8.16e-05	0.000545	CbGpPWpGaD
Rasagiline—Cough—Epirubicin—stomach cancer	8.14e-05	0.000387	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	8.14e-05	0.000544	CbGpPWpGaD
Rasagiline—Asthenia—Docetaxel—stomach cancer	8.1e-05	0.000385	CcSEcCtD
Rasagiline—Convulsion—Epirubicin—stomach cancer	8.09e-05	0.000384	CcSEcCtD
Rasagiline—Infection—Methotrexate—stomach cancer	8.09e-05	0.000384	CcSEcCtD
Rasagiline—Hypertension—Epirubicin—stomach cancer	8.06e-05	0.000383	CcSEcCtD
Rasagiline—Hypersensitivity—Capecitabine—stomach cancer	8.05e-05	0.000382	CcSEcCtD
Rasagiline—Ill-defined disorder—Doxorubicin—stomach cancer	8.01e-05	0.00038	CcSEcCtD
Rasagiline—Pruritus—Docetaxel—stomach cancer	7.99e-05	0.000379	CcSEcCtD
Rasagiline—Nervous system disorder—Methotrexate—stomach cancer	7.98e-05	0.000379	CcSEcCtD
Rasagiline—Anaemia—Doxorubicin—stomach cancer	7.98e-05	0.000379	CcSEcCtD
Rasagiline—Arthralgia—Epirubicin—stomach cancer	7.95e-05	0.000377	CcSEcCtD
Rasagiline—Chest pain—Epirubicin—stomach cancer	7.95e-05	0.000377	CcSEcCtD
Rasagiline—Agitation—Doxorubicin—stomach cancer	7.94e-05	0.000377	CcSEcCtD
Rasagiline—Anxiety—Epirubicin—stomach cancer	7.92e-05	0.000376	CcSEcCtD
Rasagiline—Skin disorder—Methotrexate—stomach cancer	7.91e-05	0.000375	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	7.89e-05	0.000375	CcSEcCtD
Rasagiline—Hyperhidrosis—Methotrexate—stomach cancer	7.87e-05	0.000374	CcSEcCtD
Rasagiline—Discomfort—Epirubicin—stomach cancer	7.85e-05	0.000373	CcSEcCtD
Rasagiline—Asthenia—Capecitabine—stomach cancer	7.84e-05	0.000372	CcSEcCtD
Rasagiline—Malaise—Doxorubicin—stomach cancer	7.79e-05	0.00037	CcSEcCtD
Rasagiline—Dry mouth—Epirubicin—stomach cancer	7.77e-05	0.000369	CcSEcCtD
Rasagiline—Vertigo—Doxorubicin—stomach cancer	7.76e-05	0.000368	CcSEcCtD
Rasagiline—Anorexia—Methotrexate—stomach cancer	7.76e-05	0.000368	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—PPP2R1A—stomach cancer	7.76e-05	0.000518	CbGpPWpGaD
Rasagiline—Syncope—Doxorubicin—stomach cancer	7.74e-05	0.000368	CcSEcCtD
Rasagiline—Pruritus—Capecitabine—stomach cancer	7.73e-05	0.000367	CcSEcCtD
Rasagiline—Leukopenia—Doxorubicin—stomach cancer	7.73e-05	0.000367	CcSEcCtD
Rasagiline—Diarrhoea—Docetaxel—stomach cancer	7.73e-05	0.000367	CcSEcCtD
Rasagiline—MAOB—Metabolism—PDHA1—stomach cancer	7.72e-05	0.000516	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ECHS1—stomach cancer	7.72e-05	0.000516	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—KRAS—stomach cancer	7.71e-05	0.000515	CbGpPWpGaD
Rasagiline—Confusional state—Epirubicin—stomach cancer	7.68e-05	0.000365	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TNF—stomach cancer	7.62e-05	0.000509	CbGpPWpGaD
Rasagiline—BCL2—Immune System—BIRC2—stomach cancer	7.61e-05	0.000508	CbGpPWpGaD
Rasagiline—Hypotension—Methotrexate—stomach cancer	7.6e-05	0.000361	CcSEcCtD
Rasagiline—Loss of consciousness—Doxorubicin—stomach cancer	7.59e-05	0.00036	CcSEcCtD
Rasagiline—Infection—Epirubicin—stomach cancer	7.57e-05	0.000359	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—VEGFA—stomach cancer	7.55e-05	0.000505	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CTSL—stomach cancer	7.54e-05	0.000504	CbGpPWpGaD
Rasagiline—Cough—Doxorubicin—stomach cancer	7.53e-05	0.000358	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	7.52e-05	0.000502	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—GSTM1—stomach cancer	7.5e-05	0.000501	CbGpPWpGaD
Rasagiline—Shock—Epirubicin—stomach cancer	7.49e-05	0.000356	CcSEcCtD
Rasagiline—Convulsion—Doxorubicin—stomach cancer	7.48e-05	0.000355	CcSEcCtD
Rasagiline—Diarrhoea—Capecitabine—stomach cancer	7.48e-05	0.000355	CcSEcCtD
Rasagiline—Nervous system disorder—Epirubicin—stomach cancer	7.47e-05	0.000355	CcSEcCtD
Rasagiline—Dizziness—Docetaxel—stomach cancer	7.47e-05	0.000355	CcSEcCtD
Rasagiline—Hypertension—Doxorubicin—stomach cancer	7.46e-05	0.000354	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Methotrexate—stomach cancer	7.41e-05	0.000352	CcSEcCtD
Rasagiline—Skin disorder—Epirubicin—stomach cancer	7.4e-05	0.000351	CcSEcCtD
Rasagiline—Hyperhidrosis—Epirubicin—stomach cancer	7.36e-05	0.00035	CcSEcCtD
Rasagiline—Insomnia—Methotrexate—stomach cancer	7.36e-05	0.00035	CcSEcCtD
Rasagiline—Arthralgia—Doxorubicin—stomach cancer	7.35e-05	0.000349	CcSEcCtD
Rasagiline—Chest pain—Doxorubicin—stomach cancer	7.35e-05	0.000349	CcSEcCtD
Rasagiline—BCL2—Immune System—MALT1—stomach cancer	7.35e-05	0.000491	CbGpPWpGaD
Rasagiline—Anxiety—Doxorubicin—stomach cancer	7.33e-05	0.000348	CcSEcCtD
Rasagiline—Paraesthesia—Methotrexate—stomach cancer	7.31e-05	0.000347	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	7.3e-05	0.000347	CcSEcCtD
Rasagiline—BCL2—Immune System—LGALS3—stomach cancer	7.29e-05	0.000487	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—TP53—stomach cancer	7.28e-05	0.000487	CbGpPWpGaD
Rasagiline—Discomfort—Doxorubicin—stomach cancer	7.26e-05	0.000345	CcSEcCtD
Rasagiline—Anorexia—Epirubicin—stomach cancer	7.26e-05	0.000345	CcSEcCtD
Rasagiline—Dyspnoea—Methotrexate—stomach cancer	7.26e-05	0.000345	CcSEcCtD
Rasagiline—MAOB—Metabolism—TYMP—stomach cancer	7.26e-05	0.000485	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—FADS1—stomach cancer	7.26e-05	0.000485	CbGpPWpGaD
Rasagiline—Somnolence—Methotrexate—stomach cancer	7.24e-05	0.000344	CcSEcCtD
Rasagiline—Dizziness—Capecitabine—stomach cancer	7.23e-05	0.000343	CcSEcCtD
Rasagiline—Dry mouth—Doxorubicin—stomach cancer	7.19e-05	0.000341	CcSEcCtD
Rasagiline—Vomiting—Docetaxel—stomach cancer	7.18e-05	0.000341	CcSEcCtD
Rasagiline—Dyspepsia—Methotrexate—stomach cancer	7.16e-05	0.00034	CcSEcCtD
Rasagiline—Rash—Docetaxel—stomach cancer	7.12e-05	0.000338	CcSEcCtD
Rasagiline—Hypotension—Epirubicin—stomach cancer	7.12e-05	0.000338	CcSEcCtD
Rasagiline—Dermatitis—Docetaxel—stomach cancer	7.11e-05	0.000338	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	7.11e-05	0.000475	CbGpPWpGaD
Rasagiline—Confusional state—Doxorubicin—stomach cancer	7.11e-05	0.000337	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—stomach cancer	7.1e-05	0.000475	CbGpPWpGaD
Rasagiline—Decreased appetite—Methotrexate—stomach cancer	7.07e-05	0.000336	CcSEcCtD
Rasagiline—Headache—Docetaxel—stomach cancer	7.07e-05	0.000336	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Methotrexate—stomach cancer	7.03e-05	0.000334	CcSEcCtD
Rasagiline—Infection—Doxorubicin—stomach cancer	7e-05	0.000332	CcSEcCtD
Rasagiline—Vomiting—Capecitabine—stomach cancer	6.95e-05	0.00033	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Epirubicin—stomach cancer	6.94e-05	0.000329	CcSEcCtD
Rasagiline—Shock—Doxorubicin—stomach cancer	6.93e-05	0.000329	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	6.92e-05	0.000462	CbGpPWpGaD
Rasagiline—Nervous system disorder—Doxorubicin—stomach cancer	6.91e-05	0.000328	CcSEcCtD
Rasagiline—Rash—Capecitabine—stomach cancer	6.89e-05	0.000327	CcSEcCtD
Rasagiline—Insomnia—Epirubicin—stomach cancer	6.89e-05	0.000327	CcSEcCtD
Rasagiline—Dermatitis—Capecitabine—stomach cancer	6.89e-05	0.000327	CcSEcCtD
Rasagiline—CYP1A2—Biological oxidations—GSTT1—stomach cancer	6.89e-05	0.00046	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—TP53—stomach cancer	6.86e-05	0.000458	CbGpPWpGaD
Rasagiline—Headache—Capecitabine—stomach cancer	6.85e-05	0.000325	CcSEcCtD
Rasagiline—Skin disorder—Doxorubicin—stomach cancer	6.85e-05	0.000325	CcSEcCtD
Rasagiline—Paraesthesia—Epirubicin—stomach cancer	6.84e-05	0.000325	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—FYN—stomach cancer	6.84e-05	0.000457	CbGpPWpGaD
Rasagiline—Hyperhidrosis—Doxorubicin—stomach cancer	6.81e-05	0.000323	CcSEcCtD
Rasagiline—CYP1A2—Biological oxidations—CYP2A6—stomach cancer	6.81e-05	0.000455	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—MAPK1—stomach cancer	6.8e-05	0.000454	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—EGFR—stomach cancer	6.79e-05	0.000454	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SREBF2—stomach cancer	6.79e-05	0.000454	CbGpPWpGaD
Rasagiline—Dyspnoea—Epirubicin—stomach cancer	6.79e-05	0.000322	CcSEcCtD
Rasagiline—Somnolence—Epirubicin—stomach cancer	6.77e-05	0.000322	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	6.77e-05	0.000452	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	6.77e-05	0.000452	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—stomach cancer	6.73e-05	0.000449	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—stomach cancer	6.73e-05	0.000449	CbGpPWpGaD
Rasagiline—Anorexia—Doxorubicin—stomach cancer	6.72e-05	0.000319	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TP53—stomach cancer	6.71e-05	0.000449	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—RORA—stomach cancer	6.71e-05	0.000449	CbGpPWpGaD
Rasagiline—Nausea—Docetaxel—stomach cancer	6.71e-05	0.000318	CcSEcCtD
Rasagiline—Feeling abnormal—Methotrexate—stomach cancer	6.71e-05	0.000318	CcSEcCtD
Rasagiline—Dyspepsia—Epirubicin—stomach cancer	6.7e-05	0.000318	CcSEcCtD
Rasagiline—Gastrointestinal pain—Methotrexate—stomach cancer	6.66e-05	0.000316	CcSEcCtD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PTGS2—stomach cancer	6.64e-05	0.000444	CbGpPWpGaD
Rasagiline—Decreased appetite—Epirubicin—stomach cancer	6.62e-05	0.000314	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—stomach cancer	6.61e-05	0.000442	CbGpPWpGaD
Rasagiline—Hypotension—Doxorubicin—stomach cancer	6.59e-05	0.000313	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Epirubicin—stomach cancer	6.58e-05	0.000312	CcSEcCtD
Rasagiline—CYP1A2—Metapathway biotransformation—AKR1C3—stomach cancer	6.53e-05	0.000436	CbGpPWpGaD
Rasagiline—Constipation—Epirubicin—stomach cancer	6.51e-05	0.000309	CcSEcCtD
Rasagiline—Nausea—Capecitabine—stomach cancer	6.49e-05	0.000308	CcSEcCtD
Rasagiline—Urticaria—Methotrexate—stomach cancer	6.47e-05	0.000307	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	6.44e-05	0.000431	CbGpPWpGaD
Rasagiline—Body temperature increased—Methotrexate—stomach cancer	6.43e-05	0.000305	CcSEcCtD
Rasagiline—Abdominal pain—Methotrexate—stomach cancer	6.43e-05	0.000305	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Doxorubicin—stomach cancer	6.42e-05	0.000305	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—FGFR2—stomach cancer	6.42e-05	0.000429	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—stomach cancer	6.4e-05	0.000428	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	6.39e-05	0.000427	CbGpPWpGaD
Rasagiline—Insomnia—Doxorubicin—stomach cancer	6.37e-05	0.000303	CcSEcCtD
Rasagiline—Paraesthesia—Doxorubicin—stomach cancer	6.33e-05	0.0003	CcSEcCtD
Rasagiline—MAOB—Metabolism—ALDOB—stomach cancer	6.29e-05	0.00042	CbGpPWpGaD
Rasagiline—Dyspnoea—Doxorubicin—stomach cancer	6.28e-05	0.000298	CcSEcCtD
Rasagiline—Feeling abnormal—Epirubicin—stomach cancer	6.28e-05	0.000298	CcSEcCtD
Rasagiline—Somnolence—Doxorubicin—stomach cancer	6.27e-05	0.000297	CcSEcCtD
Rasagiline—Gastrointestinal pain—Epirubicin—stomach cancer	6.23e-05	0.000296	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—stomach cancer	6.21e-05	0.000415	CbGpPWpGaD
Rasagiline—Dyspepsia—Doxorubicin—stomach cancer	6.2e-05	0.000295	CcSEcCtD
Rasagiline—Decreased appetite—Doxorubicin—stomach cancer	6.13e-05	0.000291	CcSEcCtD
Rasagiline—BCL2—Immune System—IRF1—stomach cancer	6.11e-05	0.000409	CbGpPWpGaD
Rasagiline—Gastrointestinal disorder—Doxorubicin—stomach cancer	6.08e-05	0.000289	CcSEcCtD
Rasagiline—Urticaria—Epirubicin—stomach cancer	6.05e-05	0.000287	CcSEcCtD
Rasagiline—Constipation—Doxorubicin—stomach cancer	6.03e-05	0.000286	CcSEcCtD
Rasagiline—Abdominal pain—Epirubicin—stomach cancer	6.02e-05	0.000286	CcSEcCtD
Rasagiline—Body temperature increased—Epirubicin—stomach cancer	6.02e-05	0.000286	CcSEcCtD
Rasagiline—Hypersensitivity—Methotrexate—stomach cancer	6e-05	0.000285	CcSEcCtD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	5.94e-05	0.000397	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—PIK3CA—stomach cancer	5.9e-05	0.000394	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IRS2—stomach cancer	5.88e-05	0.000393	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	5.87e-05	0.000392	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALOX5—stomach cancer	5.85e-05	0.000391	CbGpPWpGaD
Rasagiline—Asthenia—Methotrexate—stomach cancer	5.84e-05	0.000277	CcSEcCtD
Rasagiline—Feeling abnormal—Doxorubicin—stomach cancer	5.81e-05	0.000276	CcSEcCtD
Rasagiline—Gastrointestinal pain—Doxorubicin—stomach cancer	5.76e-05	0.000274	CcSEcCtD
Rasagiline—Pruritus—Methotrexate—stomach cancer	5.76e-05	0.000273	CcSEcCtD
Rasagiline—MAOB—Metabolism—DPYD—stomach cancer	5.75e-05	0.000385	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL1RN—stomach cancer	5.69e-05	0.00038	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	5.68e-05	0.00038	CbGpPWpGaD
Rasagiline—Hypersensitivity—Epirubicin—stomach cancer	5.61e-05	0.000266	CcSEcCtD
Rasagiline—Urticaria—Doxorubicin—stomach cancer	5.6e-05	0.000266	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—stomach cancer	5.59e-05	0.000374	CbGpPWpGaD
Rasagiline—Body temperature increased—Doxorubicin—stomach cancer	5.57e-05	0.000265	CcSEcCtD
Rasagiline—Abdominal pain—Doxorubicin—stomach cancer	5.57e-05	0.000265	CcSEcCtD
Rasagiline—Diarrhoea—Methotrexate—stomach cancer	5.57e-05	0.000264	CcSEcCtD
Rasagiline—Asthenia—Epirubicin—stomach cancer	5.46e-05	0.000259	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—HRAS—stomach cancer	5.46e-05	0.000365	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IL6ST—stomach cancer	5.4e-05	0.000361	CbGpPWpGaD
Rasagiline—Pruritus—Epirubicin—stomach cancer	5.39e-05	0.000256	CcSEcCtD
Rasagiline—Dizziness—Methotrexate—stomach cancer	5.38e-05	0.000256	CcSEcCtD
Rasagiline—BCL2—Immune System—CD44—stomach cancer	5.31e-05	0.000355	CbGpPWpGaD
Rasagiline—Diarrhoea—Epirubicin—stomach cancer	5.21e-05	0.000247	CcSEcCtD
Rasagiline—Hypersensitivity—Doxorubicin—stomach cancer	5.19e-05	0.000247	CcSEcCtD
Rasagiline—Vomiting—Methotrexate—stomach cancer	5.17e-05	0.000246	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—stomach cancer	5.15e-05	0.000344	CbGpPWpGaD
Rasagiline—Rash—Methotrexate—stomach cancer	5.13e-05	0.000244	CcSEcCtD
Rasagiline—Dermatitis—Methotrexate—stomach cancer	5.13e-05	0.000243	CcSEcCtD
Rasagiline—Headache—Methotrexate—stomach cancer	5.1e-05	0.000242	CcSEcCtD
Rasagiline—MAOB—Metabolism—GSTT1—stomach cancer	5.09e-05	0.00034	CbGpPWpGaD
Rasagiline—Asthenia—Doxorubicin—stomach cancer	5.06e-05	0.00024	CcSEcCtD
Rasagiline—Dizziness—Epirubicin—stomach cancer	5.04e-05	0.000239	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	5.04e-05	0.000336	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	5.03e-05	0.000336	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—stomach cancer	5.03e-05	0.000336	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP2A6—stomach cancer	5.03e-05	0.000336	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HBEGF—stomach cancer	5e-05	0.000334	CbGpPWpGaD
Rasagiline—Pruritus—Doxorubicin—stomach cancer	4.99e-05	0.000237	CcSEcCtD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	4.98e-05	0.000332	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AKR1C3—stomach cancer	4.89e-05	0.000327	CbGpPWpGaD
Rasagiline—Vomiting—Epirubicin—stomach cancer	4.84e-05	0.00023	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—CASP8—stomach cancer	4.83e-05	0.000323	CbGpPWpGaD
Rasagiline—Nausea—Methotrexate—stomach cancer	4.83e-05	0.00023	CcSEcCtD
Rasagiline—Diarrhoea—Doxorubicin—stomach cancer	4.82e-05	0.000229	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—IL6R—stomach cancer	4.82e-05	0.000322	CbGpPWpGaD
Rasagiline—Rash—Epirubicin—stomach cancer	4.8e-05	0.000228	CcSEcCtD
Rasagiline—Dermatitis—Epirubicin—stomach cancer	4.8e-05	0.000228	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	4.79e-05	0.00032	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	4.79e-05	0.00032	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—GSTP1—stomach cancer	4.77e-05	0.000319	CbGpPWpGaD
Rasagiline—Headache—Epirubicin—stomach cancer	4.77e-05	0.000227	CcSEcCtD
Rasagiline—MAOB—Metabolism—ENO1—stomach cancer	4.77e-05	0.000319	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	4.76e-05	0.000318	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—GSTP1—stomach cancer	4.71e-05	0.000315	CbGpPWpGaD
Rasagiline—Dizziness—Doxorubicin—stomach cancer	4.66e-05	0.000221	CcSEcCtD
Rasagiline—Nausea—Epirubicin—stomach cancer	4.52e-05	0.000215	CcSEcCtD
Rasagiline—BCL2—Immune System—PPP2R1A—stomach cancer	4.52e-05	0.000302	CbGpPWpGaD
Rasagiline—Vomiting—Doxorubicin—stomach cancer	4.48e-05	0.000213	CcSEcCtD
Rasagiline—Rash—Doxorubicin—stomach cancer	4.44e-05	0.000211	CcSEcCtD
Rasagiline—Dermatitis—Doxorubicin—stomach cancer	4.44e-05	0.000211	CcSEcCtD
Rasagiline—Headache—Doxorubicin—stomach cancer	4.41e-05	0.00021	CcSEcCtD
Rasagiline—CYP1A2—Biological oxidations—GSTM1—stomach cancer	4.39e-05	0.000293	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—GSTM1—stomach cancer	4.33e-05	0.000289	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CD44—stomach cancer	4.23e-05	0.000283	CbGpPWpGaD
Rasagiline—Nausea—Doxorubicin—stomach cancer	4.19e-05	0.000199	CcSEcCtD
Rasagiline—CYP1A2—Metabolism—ACAD8—stomach cancer	4.1e-05	0.000274	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	4.04e-05	0.00027	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—ERBB2—stomach cancer	4.03e-05	0.000269	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	4.01e-05	0.000268	CbGpPWpGaD
Rasagiline—BCL2—Immune System—FYN—stomach cancer	3.98e-05	0.000266	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	3.77e-05	0.000252	CbGpPWpGaD
Rasagiline—BCL2—Immune System—FGFR2—stomach cancer	3.74e-05	0.00025	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CDKN1B—stomach cancer	3.73e-05	0.000249	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GMPR2—stomach cancer	3.66e-05	0.000244	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPP2R1A—stomach cancer	3.6e-05	0.00024	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—JUN—stomach cancer	3.55e-05	0.000237	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	3.53e-05	0.000236	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GSTP1—stomach cancer	3.53e-05	0.000236	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	3.49e-05	0.000233	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HMOX1—stomach cancer	3.48e-05	0.000232	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CDKN1A—stomach cancer	3.45e-05	0.00023	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IRS2—stomach cancer	3.42e-05	0.000229	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MAPK8—stomach cancer	3.36e-05	0.000225	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—IDH3B—stomach cancer	3.34e-05	0.000224	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SUCLG1—stomach cancer	3.34e-05	0.000224	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—TYMS—stomach cancer	3.28e-05	0.000219	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GSTM1—stomach cancer	3.24e-05	0.000217	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PRKCB—stomach cancer	3.16e-05	0.000211	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL6ST—stomach cancer	3.15e-05	0.00021	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NDUFV1—stomach cancer	3.11e-05	0.000208	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NDUFS1—stomach cancer	3.11e-05	0.000208	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ERCC2—stomach cancer	3.05e-05	0.000204	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	3.04e-05	0.000203	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MAPK3—stomach cancer	2.94e-05	0.000196	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—MTHFR—stomach cancer	2.86e-05	0.000191	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CASP8—stomach cancer	2.82e-05	0.000188	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL6R—stomach cancer	2.81e-05	0.000188	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MAPK1—stomach cancer	2.79e-05	0.000187	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—EGFR—stomach cancer	2.79e-05	0.000187	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CDH1—stomach cancer	2.78e-05	0.000186	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PGLS—stomach cancer	2.77e-05	0.000185	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—BLVRB—stomach cancer	2.77e-05	0.000185	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPAP2A—stomach cancer	2.64e-05	0.000177	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CAV1—stomach cancer	2.64e-05	0.000177	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—KRAS—stomach cancer	2.64e-05	0.000176	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOA1—stomach cancer	2.64e-05	0.000176	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	2.54e-05	0.00017	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PIK3CA—stomach cancer	2.42e-05	0.000162	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—FBP1—stomach cancer	2.36e-05	0.000157	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NDUFA2—stomach cancer	2.36e-05	0.000157	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CKB—stomach cancer	2.36e-05	0.000157	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CA1—stomach cancer	2.36e-05	0.000157	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ERBB2—stomach cancer	2.35e-05	0.000157	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPARG—stomach cancer	2.32e-05	0.000155	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—HRAS—stomach cancer	2.24e-05	0.00015	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLIN2—stomach cancer	2.22e-05	0.000148	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CDKN1B—stomach cancer	2.17e-05	0.000145	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CA2—stomach cancer	2.16e-05	0.000144	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IL6—stomach cancer	2.15e-05	0.000143	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL1B—stomach cancer	2.14e-05	0.000143	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NT5E—stomach cancer	2.1e-05	0.00014	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PGAM1—stomach cancer	2.1e-05	0.00014	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALB—stomach cancer	2.09e-05	0.00014	CbGpPWpGaD
Rasagiline—BCL2—Immune System—JUN—stomach cancer	2.07e-05	0.000138	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CDKN1A—stomach cancer	2.01e-05	0.000134	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLCE1—stomach cancer	2e-05	0.000134	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALDH7A1—stomach cancer	2e-05	0.000134	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NOS3—stomach cancer	2e-05	0.000133	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MAPK8—stomach cancer	1.96e-05	0.000131	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—UMPS—stomach cancer	1.92e-05	0.000128	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTGS2—stomach cancer	1.83e-05	0.000122	CbGpPWpGaD
Rasagiline—BCL2—Immune System—STAT3—stomach cancer	1.79e-05	0.00012	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PDHA1—stomach cancer	1.79e-05	0.000119	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ECHS1—stomach cancer	1.79e-05	0.000119	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MAPK3—stomach cancer	1.71e-05	0.000114	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—FADS1—stomach cancer	1.68e-05	0.000112	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—TYMP—stomach cancer	1.68e-05	0.000112	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MAPK1—stomach cancer	1.63e-05	0.000109	CbGpPWpGaD
Rasagiline—BCL2—Immune System—EGFR—stomach cancer	1.63e-05	0.000109	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SREBF2—stomach cancer	1.57e-05	0.000105	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—RORA—stomach cancer	1.55e-05	0.000104	CbGpPWpGaD
Rasagiline—BCL2—Immune System—KRAS—stomach cancer	1.54e-05	0.000103	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALDOB—stomach cancer	1.46e-05	9.73e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PIK3CA—stomach cancer	1.41e-05	9.44e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.37e-05	9.17e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.37e-05	9.15e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALOX5—stomach cancer	1.35e-05	9.05e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—DPYD—stomach cancer	1.33e-05	8.9e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HRAS—stomach cancer	1.31e-05	8.73e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL6—stomach cancer	1.25e-05	8.36e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.21e-05	8.07e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSTT1—stomach cancer	1.18e-05	7.87e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP2A6—stomach cancer	1.16e-05	7.78e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AKR1C3—stomach cancer	1.13e-05	7.57e-05	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PIK3CA—stomach cancer	1.12e-05	7.51e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ENO1—stomach cancer	1.1e-05	7.37e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.09e-05	7.25e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CD44—stomach cancer	9.79e-06	6.54e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	9.49e-06	6.34e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPP2R1A—stomach cancer	8.32e-06	5.56e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSTP1—stomach cancer	8.16e-06	5.45e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HMOX1—stomach cancer	8.05e-06	5.38e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—TYMS—stomach cancer	7.59e-06	5.07e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSTM1—stomach cancer	7.5e-06	5.01e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ERCC2—stomach cancer	7.05e-06	4.71e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MTHFR—stomach cancer	6.63e-06	4.43e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CAV1—stomach cancer	6.11e-06	4.09e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOA1—stomach cancer	6.1e-06	4.08e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.84e-06	3.9e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPARG—stomach cancer	5.38e-06	3.59e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALB—stomach cancer	4.83e-06	3.23e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NOS3—stomach cancer	4.62e-06	3.09e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTGS2—stomach cancer	4.23e-06	2.83e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PIK3CA—stomach cancer	2.6e-06	1.74e-05	CbGpPWpGaD
